A DNA chip used to predict inflammatory bowel disease (IBD) prognosis is more cost effective than current clinical practice

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.584, 2009-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 892-900

Bentham Science Publishers

Access to resources Recommend Favorite

Mercaptopurine more cost effective than mesalazine in Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Current pharmacotherapy for inflammatory bowel disease

By McKaig B.C.   Stack W.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 3-14

Informa Healthcare

Access to resources Recommend Favorite

Aspirin more cost effective than clopidogrel in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite